A-04 Prevention and Treatment for Liver Cancer
- Technology Benefits
- ΓùÅ Providing effective treatment for liver cancer or preventive medicine for liver cancerΓùÅ Available Orally
- Technology Application
- ΓùÅ Suitable as preventive medicine for liver cancerΓùÅ New therapeutic method for liver cancer
- Detailed Technology Description
- This technology provides a method to prevent and treat liver cancer. The inhibition of liver cancer development was observed in a rat model by injecting both menatetrenone (a type of vitamin K) and phospholipids (preferably egg yolk lecithin or soybean lecithin). This compound can be formulated as tablets, granules, capsule, syrup, injection, or ointment.
- Supplementary Information
- Inventor: NAKAO, Akimasa | SAKAKIMA, Katsutoshi
Priority Number: WO2007091557A1
IPC Current: A61K0031122 | A61K0031685 | A61P003500
Assignee Applicant: National University Corporation Nagoya University
Title: PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF LIVER CANCER | PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT OU LA PRÉVENTION DU CANCER DU FOIE
Usefulness: PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF LIVER CANCER | PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT OU LA PRÉVENTION DU CANCER DU FOIE
Summary: For treating or preventing hepatic carcinoma (claimed).
Novelty: Pharmaceutical composition useful for preventing or treating hepatic carcinoma, comprises vitamin K and phosphatide
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Cancer/Tumor
- *Abstract
-
Researchers at Nagoya University have invented a method to safely and effectivelyprevent/treat liver cancer with two substances. This composition is a mixture of vitamin K and lecithin.
- Country/Region
- USA
For more information, please click Here
